Project Grant R01AI191573
Award Date 8/12/25
Completion Date 7/31/30
Dollars Obligated $963K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
North Carolina, USA
Similar Awards
- This federal Project Grant award for $657,907 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) will support a 5-year longitudinal analysis to understand the impact of expanding pharmacists' scope of practice on the uptake and retention of pre-exposure prophylaxis (PrEP) for HIV prevention. The project aims to integrate multiple data sources, including policy, census, survey, and medical claims data, to...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $226,902 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Alabama at Birmingham (UAB) for the "Pharmacy-Centered Rapid ARV Network: Capacity-Building for Status-Neutral ART/PrEP Services within Southern Community Pharmacies" project. The grant aims to evaluate key determinants for implementing a test-to-treat, status-neutral rapid antiretroviral (ARV)...
- This federal Project Grant award of $1,066,077 was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research (CFDA 93.855) program. The grant will fund a Type 3 hybrid effectiveness-implementation study to evaluate the "PrEP & Soccer" intervention delivered through CVS pharmacy locations in Miami-Dade, Florida. The intervention aims to increase PrEP knowledge and initial PrEP appointment attendance among...
- This $2,287,436 Project Grant award from the National Institute of Mental Health (CFDA 93.242 - Mental Health Research Grants) supports a study titled "Integrated HIV and Overdose Prevention in Pharmacies: Assessing Availability and Implementation Strategies in Different Policy Environments (HIP-PHARM)." The key objectives are to: 1) assess changes in the availability of HIV and overdose prevention services at community and retail pharmacies in Illinois and North Carolina; 2) examine...
- The University of Chicago received a $126,435 Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) to pilot the implementation of electronic patient-reported sexual health data into electronic medical records (EMRs) to identify individuals who would benefit from pre-exposure prophylaxis (PrEP) for HIV prevention. The project, titled "INFOHIV: Clinical Informatics for Optimizing HIV Prevention and...
- The University of Washington was awarded a $985,308 Project Grant from the National Institute of Child Health and Human Development (CFDA 93.865 - Child Health and Human Development Extramural Research) to advance pharmacy-based delivery of primary sexually transmitted infection (STI) and HIV prevention for cisgender women in Kenya. The funding supports research to evaluate strategies for addressing STIs and promoting HIV pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) uptake...
- This $677,589 Project Grant award from the National Institutes of Health (NIH) Office of the Director's Trans-NIH Research Support program (CFDA 93.310) supports the development and pilot testing of a novel HIV prevention program targeting women experiencing incarceration. The "FIT for PrEP" (F4P) program aims to link these high-risk women to post-release pre-exposure prophylaxis (PrEP) services and address associated social determinants of health during community re-entry. Key aspects...
- The Department of Health and Human Services National Institutes of Health (NIH) awarded a $250,000 Project Grant under the Trans-NIH Research Support program (CFDA 93.310) to the Fred Hutchinson Cancer Center, also known as the Seattle Cancer Care Alliance, to conduct a hybrid effectiveness-implementation cluster-randomized controlled trial across 20 pharmacies in Kenya. The goal of the project is to leverage telehealth to optimize the delivery of pre-exposure prophylaxis (PrEP) and...
- This $249,890 Rural Health Care Services Outreach grant, awarded by the U.S. Department of Health and Human Services' Health Resources and Services Administration (CFDA 93.912), aims to establish and sustain pharmacy-based HIV prevention and harm reduction services in rural Southern California. The project, led by Loma Linda University, will focus on increasing access to culturally responsive HIV prevention and substance use disorder treatment for underserved Black and Latinx communities in...
- This $1,272,341 cooperative agreement from the Centers for Disease Control and Prevention will support efforts to promote pre-exposure prophylaxis (PrEP) adherence among men who have sex with men of color. Awarded under the HIV Demonstration, Research, Public and Professional Education Projects program (CFDA 93.941), the University of North Carolina at Chapel Hill will work to develop and test improved HIV prevention strategies from September 2021 through October 2022. A subaward of $250,000...